The data demonstrate that the AD-associated CD33 rs3865444CC risk allele modulates the interaction between CD33 and SHP-1 in a phosphorylation-sensitive manner, potentially contributing to altered microglial function in AD. The gene discussed is PTPN6; the disease is Alzheimer disease.